Amiloride was shown to block cortical spreading depression, the experimental correlate of migraine aura, and inhibited trigeminal activation in in vivo migraine models, via an ASIC1‐dependent mechanism (Holland et al. The gene discussed is ASIC1; the disease is depressive disorder.